{"identifier":"fe8bd7ca-2cce-4e10-b839-7d49db2ae50f","data":{"title":"Comprehensive ESRD Care Model Data Dictionary","fields":[{"name":"ESCO_name","label":"Name of ESCO","description":"Name of ESCO."},{"name":"Performance_period","label":"Period of Performance","description":"Period of Performance."},{"name":"ESCO_effective_date","label":"ESCO Effective Date","description":"ESCO Start date for the CEC Model."},{"name":"ESCO_end_date","label":"ESCO End Date","description":"ESCO End date for the Period of Performance."},{"name":"LDO_indicator","label":"Large Dialysis Organization Indicator","description":"If LDO_Indicator=Y then ESCO Belongs to Large Dialysis Organization or otherwise."},{"name":"Prvdr_type_participant_non_owner","label":"Provider Participant Type - Non Owner","description":"Provider Type: Participant Non-Owner."},{"name":"Prvdr_type_participant_owner","label":"Provider Participant Type - Owner","description":"Provider Type: Participant Owner."},{"name":"Prvdr_type_provider_or_supplier","label":"Provider Participant Type - Provider or Supplier","description":"Provider Type: Provider\/Supplier."},{"name":"Num_prvdrs","label":"Number of Providers","description":"Number of Providers attached to the ESCO."},{"name":"N_dial_fac_attached","label":"Number of Dialysis Facilities","description":"Number of Dialysis Facilities attached to the ESCO."},{"name":"Aligned_bene","label":"Aligned Beneficiaries","description":"Total number of aligned beneficiaries, performance year."},{"name":"Age_grp_0_64","label":"Total Assigned Beneficiaries, Age 0-64","description":"Total number of assigned beneficiaries, age 0-64 in CY 2017; age calculated as of 12\/31\/2017. Based on most current date of birth in Medicare records."},{"name":"Age_grp_65_74","label":"Total Assigned Beneficiaries, Age 65-74","description":"Total number of assigned beneficiaries, age 65-74 in CY 2017; age calculated as of 12\/31\/2017. Based on most current date of birth in Medicare records."},{"name":"Age_grp_75_84","label":"Total Assigned Beneficiaries, Age 75-84","description":"Total number of assigned beneficiaries, age 75-84 in CY 2017; age calculated as of 12\/31\/2017. Based on most current date of birth in Medicare records."},{"name":"Age_grp_85_plus","label":"Total Assigned Beneficiaries, Age 85+","description":"Total number of assigned beneficiaries, age 85+ in CY 2017; age calculated as of 12\/31\/2017. Based on most current date of birth in Medicare records."},{"name":"Male","label":"Total Assigned Beneficiaries, Male","description":"Total number of assigned beneficiaries, male (Sex=1) in CY 2017. Based on most current sex in Medicare records."},{"name":"Female","label":"Total Assigned Beneficiaries, Female","description":"Total number of assigned beneficiaries, female (Sex=2) in CY 2017. Based on most current sex in Medicare records."},{"name":"ICH_CAHPS_nephrologists_communication_and_caring","label":"Nephrologists Care Coordination","description":"Nephrologists\u0027 Communication and Caring."},{"name":"ICH_CAHPS_providing_information_to_patients","label":"Providing Information to Patients","description":"Providing Information to Patients."},{"name":"ICH_CAHPS_rating_of_dialysis_center","label":"Quality of Dialysis Center Care and Operation","description":"Quality of Dialysis Center Care and Operation."},{"name":"ICH_CAHPS_dialysis_center_care_and_operations","label":"Rating Facility","description":"Rating of the Dialysis Facility."},{"name":"ICH_CAHPS_rating_of_dialysis_center_staff","label":"Rating of Dialysis Staff","description":"Rating of Dialysis Center Staff."},{"name":"ICH_CAHPS_rating_of_kidney_doctors","label":"Nephrologist Ratings","description":"Rating of Kidney Doctors."},{"name":"Advance_care_plan","label":"Advance Care Rate","description":"Percentage of ESCO aligned beneficiaries who had evidence of advance care planning during the measurement year."},{"name":"Depression_screen_rate","label":"Screening for Clinical Depression and Follow-Up Plan","description":"Percentage of ESCO aligned beneficiaries who were screened for clinical depression using an age-appropriate standardized depression screening tool from January 1 to December 1 AND, if positive, for which follow-up care within 30 days (inclusive) was documented during the measurement year."},{"name":"Diabetes_care_eye_exam","label":"Diabetes Eye Exam","description":"Percentage of ESCO aligned beneficiaries age 18 to 75 with diabetes (type 1 or type 2) who had an eye exam (retinal) performed."},{"name":"Diabetes_care_foot_exam","label":"Diabetes Foot Exam","description":"Percentage of ESCO aligned beneficiaries age 18 to 75 with diabetes (type 1 and type 2) who received a foot exam (visual inspection and sensory exam with mono filament and a pulse exam) during the measurement year."},{"name":"Falls_plan_of_care","label":"Falls Plan Rate","description":"Plan of Care to Prevent Future Falls: Percentage of ESCO aligned beneficiaries with a history of falls that had a plan of care for falls documented within the measurement year."},{"name":"Falls_risk_assessment","label":"Fall Risk Rate","description":"Risk Assessment: Percentage of ESCO aligned beneficiaries with a history of falls that had a risk assessment for falls completed within the measurement year."},{"name":"Falls_screening","label":"Fall Screening","description":"Screening for Future Fall Risk: Percentage of ESCO aligned beneficiaries who were screened for future fall risk at least once within the measurement year."},{"name":"Influenza_immunization","label":"Influenza Immunization in the ESRD Population","description":"Percentage of ESCO aligned beneficiaries who received the influenza vaccine from July 1 to December 31 of the measurement year."},{"name":"Medication_reconciliation","label":"Medication Reconciliation Post Discharge","description":"Percentage of discharges from January 1 to December 1 of the measurement year for ESCO aligned beneficiaries for whom medications were reconciled on the date of discharge through 30 days after discharge (31 total days)."},{"name":"Pneumococcal_vaccination_status","label":"Pneumococcal Vaccination","description":"Percentage of ESCO aligned beneficiaries who received one or more pneumococcal vaccinations by the end of the measurement year."},{"name":"Tobacco_use_rate","label":"Tobacco Use: Screening and Cessation Intervention","description":"Percentage of ESCO aligned beneficiaries who were screened for tobacco use at least once during the measurement year AND who received cessation intervention if identified as a tobacco user."},{"name":"Standardized_mortality_ratio","label":"Degree of ESCO\u0027S SMR","description":"The degree to which the ESCO\u2019s SMR varies from 1.00 is the measurement of the degree to which the overall mortality rate at that ESCO is greater than (SMR \u0026gt;1.00) or less than (SMR \u0026lt;1.00) the national mortality rate for patients with the same characteristics."},{"name":"T_PPPW","label":"Percentage of Patients at Each Dialysis Facility Who Were on the Kidney or Kidney-Pancreas Transplant Waitlist","description":"ESCO-level standardized measure that reports the percentage of patients at each dialysis facility who were on the kidney or kidney-pancreas transplant waitlist. Results are averaged across patients prevalent on the last day of each month during the reporting year."},{"name":"T_SWR","label":"Number of Incident Patients at the Dialysis Facility Under the Age of 75 Listed on the Kidney or Kidney-Pancreas Transplant Waitlist","description":"ESCO-level standardized ratio measure that reports the number of incident patients at the dialysis facility under the age of 75 listed on the kidney or kidney-pancreas transplant waitlist or who received living donor transplants within the first year of initiating dialysis."},{"name":"Overall_TQS","label":"Quality Score","description":"The Quality Scoring Methodology includes weights for each quality measure to reflect its respective contribution to the ESCO Total Quality Score (TQS).  The methodology assigns outcome quality measures a weight of 3 and process quality measures a weight of 2.  The quality measures with QIP results as their data source are assigned a weight of 1. Notably, the ICH CAHPS survey includes six reported measures, each of which are assigned a weight of 1 so the survey as a whole contributes a weight of 6."},{"name":"PBPY_exp_ESRD_only_BY1","label":"PBPY ESRD Only Expenditures in Benchmark Year 1","description":"Total expenditures for aligned beneficiaries with ESRD enrollment divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_age_dua_BY1","label":"PBPY Aged-Dual Expenditures in Benchmark Year 1","description":"Total expenditures for aligned beneficiaries with Aged-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_age_non_dua_BY1","label":"PBPY Aged-Non-Dual Expenditures in Benchmark Year 1","description":"Total expenditures for aligned beneficiaries with Aged Non-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_disable_dua_BY1","label":"PBPY Disable-Dual Expenditures in Benchmark Year 1","description":"Total expenditures for aligned beneficiaries with Disabled Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_disable_no_dua_BY1","label":"PBPY Disable-Non-Dual Expenditures in Benchmark Year 1","description":"Total expenditures for aligned beneficiaries with Disabled Non-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_ESRD_only_BY2","label":"PBPY ESRD Only Expenditures in Benchmark Year 2","description":"Total expenditures for aligned beneficiaries with ESRD enrollment divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_age_dua_BY2","label":"PBPY Aged-Dual Expenditures in Benchmark Year 2","description":"Total expenditures for aligned beneficiaries with Aged-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_age_non_dua_BY2","label":"PBPY Aged-Non-Dual Expenditures in Benchmark Year 2","description":"Total expenditures for aligned beneficiaries with Aged Non-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_disable_dua_BY2","label":"PBPY Disable-Dual Expenditures in Benchmark Year 2","description":"Total expenditures for aligned beneficiaries with Disabled Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_disable_no_dua_BY2","label":"PBPY Disable-Non-Dual Expenditures in Benchmark Year 2","description":"Total expenditures for aligned beneficiaries with Disabled Non-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_ESRD_only_BY3","label":"PBPY ESRD Only Expenditures in Benchmark Year 3","description":"Total expenditures for aligned beneficiaries with ESRD enrollment divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_age_dua_BY3","label":"PBPY Aged-Dual Expenditures in Benchmark Year 3","description":"Total expenditures for aligned beneficiaries with Aged-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_age_non_dua_BY3","label":"PBPY Aged-Non-Dual Expenditures in Benchmark Year 3","description":"Total expenditures for aligned beneficiaries with Aged Non-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_disable_dua_BY3","label":"PBPY Disable-Dual Expenditures in Benchmark Year 3","description":"Total expenditures for aligned beneficiaries with Disabled Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"PBPY_exp_disable_no_dua_BY3","label":"PBPY Disable-Non-Dual Expenditures in Benchmark Year 3","description":"Total expenditures for aligned beneficiaries with Disabled Non-Dual enrollment  divided by the number of aligned beneficiary-years. These Per-Beneficiary-Per-Year (PBPY) figures account for the fact that some beneficiaries are aligned for only a portion of the year."},{"name":"Histbnchmk_ESRD_only_PY","label":"Historical Benchmark for Beneficiaries With ESRD Only Enrollment","description":"The Historical Expenditure Baseline is the BY1, BY2, and BY3 simple average for aligned beneficiaries with ESRD only enrollment."},{"name":"Histbnchmk_age_dua_PY","label":"Historical Benchmark for Beneficiaries With Age Dual Enrollment","description":"The Historical Expenditure Baseline is the BY1, BY2, and BY3 simple average for aligned beneficiaries with Age Dual enrollment."},{"name":"Histbnchmk_age_non_dua_PY","label":"Historical Benchmark for Beneficiaries With Age Non-Dual Enrollment","description":"The Historical Expenditure Baseline is the BY1, BY2, and BY3 simple average for aligned beneficiaries with  Age Non-Dual  enrollment."},{"name":"Histbnchmk_disable_dua_PY","label":"Historical Benchmark for Beneficiaries With Disabled Dual Enrollment","description":"The Historical Expenditure Baseline is the BY1, BY2, and BY3 simple average for aligned beneficiaries with Disabled Dual enrollment."},{"name":"Histbnchmk_disable_non_dua_PY","label":"Historical Benchmark for Beneficiaries With Disabled Non-Dual Enrollment","description":"The Historical Expenditure Baseline is the BY1, BY2, and BY3 simple average for aligned beneficiaries with Disabled Non-Dual enrollment."},{"name":"Risk_rt_ESRD_only_PY","label":"Risk Ratio for ESRD-Only in Performance Year","description":"Overall E\/C weighted average Risk Score used to calculate the Risk Score Ratio. The Risk Score Ratio used to, say, risk adjust HB expenditures to make them comparable to Model PY2 expenditures is the overall E\/C weighted Risk Score for Model PY2 divided by the overall E\/C weighted average Risk Score for BY3."},{"name":"Risk_rt_age_dua_PY","label":"Risk Ratio for Age-Dual in Performance Year","description":"Overall E\/C weighted average Risk Score used to calculate the Risk Score Ratio. The Risk Score Ratio used to, say, risk adjust HB expenditures to make them comparable to Model PY2 expenditures is the overall E\/C weighted Risk Score for Model PY2 divided by the overall E\/C weighted average Risk Score for BY3."},{"name":"Risk_rt_age_non_dua_PY","label":"Risk Ratio for Age-Non-Dual in Performance Year","description":"Overall E\/C weighted average Risk Score used to calculate the Risk Score Ratio. The Risk Score Ratio used to, say, risk adjust HB expenditures to make them comparable to Model PY2 expenditures is the overall E\/C weighted Risk Score for Model PY2 divided by the overall E\/C weighted average Risk Score for BY3."},{"name":"Risk_rt_disable_dua_PY","label":"Risk Ratio for Disable-Dual in Performance Year","description":"Overall E\/C weighted average Risk Score used to calculate the Risk Score Ratio. The Risk Score Ratio used to, say, risk adjust HB expenditures to make them comparable to Model PY2 expenditures is the overall E\/C weighted Risk Score for Model PY2 divided by the overall E\/C weighted average Risk Score for BY3."},{"name":"Risk_rt_disable_non_dua_PY","label":"Risk Ratio for Disable-Non-Dual in Performance Year","description":"Overall E\/C weighted average Risk Score used to calculate the Risk Score Ratio. The Risk Score Ratio used to, say, risk adjust HB expenditures to make them comparable to Model PY2 expenditures is the overall E\/C weighted Risk Score for Model PY2 divided by the overall E\/C weighted average Risk Score for BY3."},{"name":"Tol_benchmrk_exp_PY","label":"Total Benchmark Expenditure in Performance Year","description":"Total Benchmark Expenditure is the weighted average of PBPY discounted Expenditure Benchmark multiplied by the total eligible beneficiary-years."},{"name":"PBPY_exp_ESRD_only_PY","label":"PBPY ESRD Only Expenditures in Performance Year","description":"Total expenditures for aligned beneficiaries with ESRD only enrollment divided by the number of aligned beneficiary-years."},{"name":"PBPY_exp_age_dua_PY","label":"PBPY Age Dual Expenditures in Performance Year","description":"Total expenditures for aligned beneficiaries with Age Dual enrollment divided by the number of aligned beneficiary-years."},{"name":"PBPY_exp_age_non_dua_PY","label":"PBPY Aged Non-Dual Expenditures in Performance Year","description":"Total expenditures for aligned beneficiaries with Age-Non-Dual enrollment divided by the number of aligned beneficiary-years."},{"name":"PBPY_exp_disable_dua_PY","label":"PBPY Disable Dual Expenditures in Performance Year","description":"Total expenditures for aligned beneficiaries with Disabled Dual enrollment divided by the number of aligned beneficiary-years."},{"name":"PBPY_exp_disable_non_dua_PY","label":"PBPY Disable Non-Dual Expenditures in Performance Year","description":"Total expenditures for aligned beneficiaries with Disabled Non-Dual enrollment divided by the number of aligned beneficiary-years."},{"name":"Bene_yrs_ESRD_only_PY","label":"ESRD Person-Years in Performance Year","description":"Aligned and Eligible Beneficiary-Years: Number of beneficiary-years included in the financial calculations for  beneficiaries with ESRD enrollment type in the Performance year."},{"name":"Bene_yrs_age_dua_PY","label":"Age-Dual Person-Years in Performance Year","description":"Aligned and Eligible Beneficiary-Years: Number of beneficiary-years included in the financial calculations for  beneficiaries with Age-Dual enrollment type in the Performance year."},{"name":"Bene_yrs_age_non_dua_PY","label":"Age-Non-Dual Person-Years in Performance Year","description":"Aligned and Eligible Beneficiary-Years: Number of beneficiary-years included in the financial calculations for  beneficiaries with Age-Non-Dual enrollment type in the Performance year."},{"name":"Bene_yrs_disable_dua_PY","label":"Disable-Dual Person-Years in Performance Year","description":"Aligned and Eligible Beneficiary-Years: Number of beneficiary-years included in the financial calculations for  beneficiaries with Disable-Dual enrollment type in the Performance year."},{"name":"Bene_yrs_disable_non_dua_PY","label":"Disable-Non-Dual Person-Years in Performance Year","description":"Aligned and Eligible Beneficiary-Years: Number of beneficiary-years included in the financial calculations for  beneficiaries with Disable-Non-Dual enrollment type in the Performance year."},{"name":"Tol_bene_exp_PY","label":"Total Beneficiary Expenditure in Performance Year","description":"Total Beneficiary expenditure in performance year."},{"name":"Align_bene_yrs","label":"Aligned Beneficiary Person-Years in Performance Year in Finance","description":"The number of beneficiary-years included in the financial calculations."},{"name":"Min_sav_rate","label":"Minimum Savings Rate (%)","description":"To remain eligible for Shared Savings\/Losses, the Shared Savings\/Losses amount must meet or exceed the product of the Minimum Savings\/Losses Rate and the Total Expenditure Benchmark. One-sided non-LDOs have no responsibility for Shared Losses, and their MSRs are determined by formula. Additional detail on the formula is available from Appendix B to the CEC Model Participation Agreement. For LDOs and two-sided non-LDOs, both their MSRs and MLRs are 1-2 percent (increments of 0.5 percent) in Model PY2. These rates are selected by the ESCOs."},{"name":"Min_los_rate","label":"Minimum Losses Rate","description":"To remain eligible for Shared Savings\/Losses, the Shared Savings\/Losses amount must meet or exceed the product of the Minimum Savings\/Losses Rate and the Total Expenditure Benchmark. One-sided non-LDOs have no responsibility for Shared Losses, and their MSRs are determined by formula. Additional detail on the formula is available from Appendix B to the CEC Model Participation Agreement. For LDOs and two-sided non-LDOs, both their MSRs and MLRs are 1-2 percent (increments of 0.5 percent) in Model PY2. These rates are selected by the ESCOs."},{"name":"Min_savig_amt","label":"Minimum Savings Amount","description":"ESCO\u0027s Minimum Savings Amount."},{"name":"Min_losses_amt","label":"Minimum Losses Amount","description":"ESCO\u0027s Minimum Losses  Amount."},{"name":"Met_qscore","label":"Quality Reporting Met","description":"The ESCO must completely and accurately report quality measures. Complete reporting means that the ESCO meets all of the reporting requirements including timing and reporting the requested data for all measure."},{"name":"Gen_sav","label":"Generated Total Savings\/Losses","description":"For LDOs, Preliminary Shared Savings or Preliminary Shared Losses are capped at 10 percent of the Total PY Expenditure Benchmark in Model PY2, and at 15 percent in Model PY3 and later years. For one-sided non-LDOs, Preliminary Shared Savings are capped at 5 percent of the Total PY Expenditure Benchmark in all PYs. For two-sided non-LDOs, Preliminary Shared Savings and Preliminary Shared Losses are capped at 10 percent of the Total PY Expenditure Benchmark in Model PY2 and 15 percent in Model PY3 and later years. Finally, as part of the Budget Control Act of 2011, payments to Medicare providers were reduced by 2 percent beginning on April 1, 2013. To calculate shared savings on a pre-sequestration basis, we remove the effect of sequestration from all payments occurring during the time that sequestration was in effect. By law, preliminary Shared Savings amounts are subject to the 2 percent sequestration reduction, and will be adjusted for sequestration."},{"name":"Sav_rate","label":"Savings Rate","description":"Total shared savings\/lossess divided by Total Benchmark Expenditures."}]}}